F2L, a peptide derived from heme‐binding protein, inhibits LL‐37‐induced cell proliferation and tube formation in human umbilical vein endothelial cells

Authors:
  • MLMi-Sook Lee
    Mi-Sook Lee
  • HLHa Young Lee
    Ha Young Lee
  • SKSang Doo Kim
    Sang Doo Kim
  • JSJae Woong Shim
    Jae Woong Shim
  • SJSeong Ho Jo
    Seong Ho Jo
  • JLJae Won Lee
    Jae Won Lee
  • JKJoon Youn Kim
    Joon Youn Kim
  • YCYoung-Whan Choi
    Young-Whan Choi
  • SBSuk-Hwan Baek
    Suk-Hwan Baek
  • YBYoe-Sik Bae
    Yoe-Sik Bae

Abstract
F2L, a peptide derived from heme‐binding protein, was originally identified as an endogenous ligand for formyl peptide receptor‐like (FPRL)2. Previously, we reported that F2L inhibits FPR and FPRL1‐mediated signaling in neutrophils. Since endothelial cells express functional FPRL1, we examined the effect of F2L on LL‐37 (an FPRL1 agonist)‐induced signaling in human umbilical vein endothelial cells (HUVECs). F2L stimulated the chemotactic migration in HUVECs. However, F2L inhibited FPRL1 activity, resulting in the inhibition of cell proliferation and tube formation induced by LL‐37 in HUVECs. We suggest that F2L will potentially be useful in the study of FPRL1 signaling and the development of drugs to treat diseases involving the FPRL1 in the vascular system.

This publication has 29 references indexed in Scilit: